As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
L’expertise universitaire, l’exigence journalistique
Articles sur Vaccines
Affichage de 521 à 540 de 786 articles
If the vaccine does not protect individuals from infection, those who have been vaccinated could falsely believe they are protected.
We all have the right to refuse medical treatment, but the government could penalise those who refuse a COVID-19 vaccine.
Whether a coronavirus vaccine involves a live virus or a carrier organism, it will probably require more than one injection. But that’s not a bad thing.
Instead of a global response to the pandemic, we’re seeing an outbreak of vaccine nationalism.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
The Russian cyberthreat, now targeting coronavirus vaccine research, goes back over three decades, extends into the country’s educational systems and criminal worlds, and shows no signs of letting up.
For a COVID-19 vaccine to stop the pandemic, a large percentage of the population will have to get vaccinated. A law professor explains how far government and employer vaccine mandates can legally go.
The experimental vaccine stimulates the creation of antibodies. Now we need to show that these effectively protect us from the coronavirus.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
A vaccine that’s 70% effective might not be good enough if too few people are willing to be vaccinated, new research shows.
Some viruses are similar enough that just one vaccine is needed to treat them all.
Nanoparticles dressed up in cell membranes snag SARS-CoV-2 virus particles before they reach human cells.
Vaccine development usually spans a number of decades. This is because there’s a need to understand the mechanisms of protection against the pathogen, and to minimise adverse reactions.
In a pandemic like this one, the priority is to save lives. But without a vaccine, there’s a limit in the tools available to save lives.
The US has bought up most of the world’s supply of remdesivir. This type of treatment nationalism is nothing new, though.
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.
Treatment nationalism is a threat to us all.
Vaccines and antivirals aren’t the only game in town.
A mutating coronavirus has implications for vaccines, treatments, tests and your future plans.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Professor of Microbiology, School of Medicine, University of Washington
-
Associate Professor of Biology, Rochester Institute of Technology
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Senior Lecturer; MD, Victoria University
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Professor of Immunology, RMIT University
